{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:15:50Z","timestamp":1740633350496,"version":"3.38.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.7759\/cureus.79668","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:05:23Z","timestamp":1740557123000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification of an Ultra-Rare GLA Frameshift Variant in a South African Family With Hypertrophic Cardiomyopathy: A Case Report"],"prefix":"10.7759","author":[{"given":"Timothy F","family":"Spracklen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polycarp","family":"Ndibangwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ntobeko A","family":"B. Ntusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gasnat","family":"Shaboodien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron BJ","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995, 92:785-9. 10.1161\/01.cir.92.4.785","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian AJ","year":"2017","unstructured":"Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017, 121:749-70. 10.1161\/CIRCRESAHA.117.311059","journal-title":"Circ Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq073","article-title":"Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women","volume":"12","author":"Havndrup O","year":"2010","unstructured":"Havndrup O, Christiansen M, Stoevring B, et al.. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail. 2010, 12:535-40. 10.1093\/eurjhf\/hfq073","journal-title":"Eur J Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart A","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007, 28:1228-35. 10.1093\/eurheartj\/ehm153","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001605","article-title":"Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Mayosi BM","year":"2017","unstructured":"Mayosi BM, Fish M, Shaboodien G, et al.. Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2017, 10:001605. 10.1161\/CIRCGENETICS.116.001605","journal-title":"Circ Cardiovasc Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref7","article-title":"Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease","volume":"53","author":"Eng CM","year":"1993","unstructured":"Eng CM, Resnick-Silverman LA, Niehaus DJ, et al.. Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet. 1993, 53:1186-97.","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2732","article-title":"Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy","volume":"38","author":"Cecconi M","year":"2016","unstructured":"Cecconi M, Parodi MI, Formisano F, et al.. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy. Int J Mol Med. 2016, 38:1111-24. 10.3892\/ijmm.2016.2732","journal-title":"Int J Mol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.2353","article-title":"Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy","volume":"2","author":"Cecchi F","year":"2017","unstructured":"Cecchi F, Iascone M, Maurizi N, et al.. Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy. JAMA Cardiol. 2017, 2:1147-51. 10.1001\/jamacardio.2017.2353","journal-title":"JAMA Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat L","year":"2007","unstructured":"Monserrat L, Gimeno-Blanes JR, Mar\u00edn F, et al.. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007, 50:2399-403. 10.1016\/j.jacc.2007.06.062","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2016.52","article-title":"Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis","volume":"61","author":"Seo J","year":"2016","unstructured":"Seo J, Kim M, Hong GR, et al.. Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis. J Hum Genet. 2016, 61:775-80. 10.1038\/jhg.2016.52","journal-title":"J Hum Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2014.11.007","article-title":"Molecular insight into heart development and congenital heart disease: an update review from the Arab countries","volume":"25","author":"Aburawi EH","year":"2015","unstructured":"Aburawi EH, Aburawi HE, Bagnall KM, Bhuiyan ZA. Molecular insight into heart development and congenital heart disease: an update review from the Arab countries. Trends Cardiovasc Med. 2015, 25:291-301. 10.1016\/j.tcm.2014.11.007","journal-title":"Trends Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao S","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, et al.. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med. 1995, 333:288-93. 10.1056\/NEJM199508033330504","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2019.01.002","article-title":"Fabry disease in cardiology practice: literature review and expert point of view","volume":"112","author":"Hag\u00e8ge A","year":"2019","unstructured":"Hag\u00e8ge A, R\u00e9ant P, Habib G, et al.. Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis. 2019, 112:278-87. 10.1016\/j.acvd.2019.01.002","journal-title":"Arch Cardiovasc Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001691","article-title":"\u03b1-galactosidase A genotype N215s induces a specific cardiac variant of Fabry disease","volume":"10","author":"Oder D","year":"2017","unstructured":"Oder D, Liu D, Hu K, et al.. \u03b1-galactosidase A genotype N215s induces a specific cardiac variant of Fabry disease. Circ Cardiovasc Genet. 2017, 10:001691. 10.1161\/CIRCGENETICS.116.001691","journal-title":"Circ Cardiovasc Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-022-00859-z","article-title":"Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis","volume":"24","author":"Ponsiglione A","year":"2022","unstructured":"Ponsiglione A, Gambardella M, Green R, et al.. Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2022, 24:31. 10.1186\/s12968-022-00859-z","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"Ortiz A","year":"2018","unstructured":"Ortiz A, Germain DP, Desnick RJ, et al.. Fabry disease revisited: Management and treatment recommendations for adult patients. Mol Genet Metab. 2018, 123:416-27. 10.1016\/j.ymgme.2018.02.014","journal-title":"Mol Genet Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2021.12.004","article-title":"Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression","volume":"135","author":"van der Veen SJ","year":"2022","unstructured":"van der Veen SJ, K\u00f6rver S, Hirsch A, et al.. Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression. Mol Genet Metab. 2022, 135:163-9. 10.1016\/j.ymgme.2021.12.004","journal-title":"Mol Genet Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.230154","article-title":"Effects of enzyme replacement therapy on cardiac MRI findings in Fabry disease: a systematic review and meta-analysis","volume":"6","author":"Figliozzi S","year":"2024","unstructured":"Figliozzi S, Kollia E, Simistiras A, et al.. Effects of enzyme replacement therapy on cardiac MRI findings in Fabry disease: a systematic review and meta-analysis. Radiol Cardiothorac Imaging. 2024, 6:e230154. 10.1148\/ryct.230154","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2015.03.014","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"7","author":"Acharya D","year":"2015","unstructured":"Acharya D, Doppalapudi H, Tallaj JA. Arrhythmias in Fabry cardiomyopathy. Card Electrophysiol Clin. 2015, 7:283-91. 10.1016\/j.ccep.2015.03.014","journal-title":"Card Electrophysiol Clin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337407-identification-of-an-ultra-rare-gla-frameshift-variant-in-a-south-african-family-with-hypertrophic-cardiomyopathy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:05:24Z","timestamp":1740557124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337407-identification-of-an-ultra-rare-gla-frameshift-variant-in-a-south-african-family-with-hypertrophic-cardiomyopathy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79668","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}